Cancer vaccines specialist AilseVax is 100th spin-out company from Queen's

START-up firm AilseVax, which is developing the next generation of cancer vaccines, has become the 100th company to spin out of the laboratories at Belfast's Queen’s University.

Related Keywords

Dublin ,Ireland ,Belfast ,United Kingdom ,Northern Ireland ,Craigavon ,United States ,Republic Of Ireland ,Sarah Maguire ,Ted Lavelle ,Dan Longley ,Paul Kerr ,Simon Mcdade ,Chris Scott ,Mehdi Jafarnejad ,Queen University ,Belfast Queen University ,Eco Fund ,Northern Ireland Us National Cancer Institute Consortium ,Patrickg Johnston Centre For Cancer Research ,Trinity College Dublin ,Sapphire Capital ,Biomedical Catalyst ,Cancer Institute Consortium ,Good Friday ,Professor Ed Lavelle ,Professor Dan Longley ,Professor Chris Scott ,Patrickg Johnston Centre ,Cancer Research ,Ailsevax ,Dr Paul Kerr ,Queens University ,Spin Out ,Trinity ,Cancer Vaccines , ,